Skip to content

A comparison of shock wave versus corticosteroid for pain reduction in plantar fasciitis: randomized clinical trial

A comparison of shock wave versus corticosteroid for pain reduction in plantar fasciitis: randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014030616865N1
Enrollment
74
Registered
2014-05-19
Start date
2013-07-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar fascial fibromatosis. Plantar fascitiis

Interventions

Intervention 1: For the group shock wave three doses of 2000 pulses of energy with 10 Hz frequency and 2.5 bar pressure with the intervals of one week are applied. Intervention 2: In the group cortico
Treatment - Drugs
For the group shock wave three doses of 2000 pulses of energy with 10 Hz frequency and 2.5 bar pressure with the intervals of one week are applied.
In the group corticosteroid, a single dose of 40 mg methylprednisolone acetate (0.5 ml) mixed with 2 ml of 2% lidocaine is injected.

Sponsors

Baqiatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: more than 18 years of age; a history of heel pain for at least four weeks unresponsive to conservative treatments (NSAIDS); pain with the intensity of more than 2 in a 100 mm visual analog scale (VAS) at the baseline visit; tenderness at the medial plantar calcaneal region Exclusion criteria: evidence of calcaneal fracture on x-ray; history of heel surgery; damage to Achilles tendon; inflammatory diseases like rheumatoid arthritis; diabetes mellitus; local or systemic infections; peripheral vascular diseases; gout; blood coagulation disorders; corticosteroid injection during the last 6 months; contraindications to steroid injection; non-steroidal anti-inflammatory use within the last 7 days; Pregnant or breast feeding mothers

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity at the standing position. Timepoint: All the outcomes were evaluated at the baseline visit and at 1 week, 1 month, and 3 months after the intervention. Method of measurement: Visual analog scale.

Secondary

MeasureTime frame
Early morning pain; pain on joint movement; daily activities; climbing stairs and exercise tolerance. Timepoint: All the outcomes were evaluated at the baseline visit and at 1 week, 1 month, and 3 months after the intervention. Method of measurement: Visual analog scale. We also assess the ability to perform daily activities, climbing stairs and exercise tolerance with visual analog scale for foot and ankle (VASFA). Patients state their levels of functionality with matching it to the numbers 0 (unable to do) to 100 (without any difficulty).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Asheghan, MD

Baqiatallah University of Medical Sciences

m_asheghan@bmsu.ac.ir+98 212188058837

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026